1. Home
  2. VNO vs CAI Comparison

VNO vs CAI Comparison

Compare VNO & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vornado Realty Trust

VNO

Vornado Realty Trust

HOLD

Current Price

$27.08

Market Cap

5.1B

Sector

Real Estate

ML Signal

HOLD

CAI

Caris Life Sciences Inc.

HOLD

Current Price

$18.14

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNO
CAI
Founded
1946
2008
Country
United States
United States
Employees
3145
1846
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VNO
CAI
Price
$27.08
$18.14
Analyst Decision
Hold
Strong Buy
Analyst Count
10
10
Target Price
$33.00
$31.20
AVG Volume (30 Days)
2.2M
2.2M
Earning Date
05-04-2026
05-12-2026
Dividend Yield
2.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$25.24
Revenue Next Year
$5.42
$22.52
P/E Ratio
$7.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.57
$16.28
52 Week High
$43.37
$42.50

Technical Indicators

Market Signals
Indicator
VNO
CAI
Relative Strength Index (RSI) 53.21 44.27
Support Level $25.19 $16.98
Resistance Level $32.81 $19.66
Average True Range (ATR) 0.86 1.06
MACD 0.33 0.18
Stochastic Oscillator 82.89 48.81

Price Performance

Historical Comparison
VNO
CAI

About VNO Vornado Realty Trust

Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: